ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,233 | -28.3% | 90,318 | -11.7% | 0.00% | – |
| Q2 2023 | $686,708 | -10.5% | 102,341 | +17.8% | 0.00% | – |
| Q1 2023 | $766,956 | +61.6% | 86,858 | +39.8% | 0.00% | – |
| Q4 2022 | $474,719 | +146.0% | 62,136 | +130.1% | 0.00% | – |
| Q3 2022 | $193,000 | -5.9% | 27,005 | +6.8% | 0.00% | – |
| Q2 2022 | $205,000 | -70.3% | 25,280 | -49.1% | 0.00% | – |
| Q1 2022 | $690,000 | -50.4% | 49,652 | +0.1% | 0.00% | – |
| Q4 2021 | $1,392,000 | -21.3% | 49,602 | -4.7% | 0.00% | -100.0% |
| Q3 2021 | $1,769,000 | +183.0% | 52,058 | +240.3% | 0.00% | – |
| Q2 2021 | $625,000 | -29.4% | 15,297 | -30.4% | 0.00% | – |
| Q1 2021 | $885,000 | -34.8% | 21,981 | -4.3% | 0.00% | – |
| Q4 2020 | $1,358,000 | +4.7% | 22,967 | -13.9% | 0.00% | – |
| Q3 2020 | $1,297,000 | +16.5% | 26,678 | +15.9% | 0.00% | – |
| Q2 2020 | $1,113,000 | +50.0% | 23,012 | -13.9% | 0.00% | – |
| Q1 2020 | $742,000 | +149.8% | 26,718 | +169.1% | 0.00% | – |
| Q4 2019 | $297,000 | -20.8% | 9,930 | -18.2% | 0.00% | – |
| Q3 2019 | $375,000 | – | 12,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |